AzTrials
AzTrials

Physical InactivityEarly Phase 1STEPSNCT01264757

Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population

A Early Phase 1 study testing Physical Activity Educational Materials and Pedometer in people with Physical Inactivity, run by Pennington Biomedical Research Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This feasibility study specifically addresses the issue of adapting US dietary guidelines physical activity recommendations to the population of the Lower Mississippi Delta. The hypothesis is that including a pedometer as a self-monitoring tool as part of adapted physical activity guidelines will result in greater… Read more about this study

Who is it for?
Ages 35 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Physical Inactivity
What is being tested?
Physical Activity Educational Materials and Pedometer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteUnited States
Study dates
Feb 2010to Jun 2010
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 35 to 64 years of age
  • body mass index (BMI) between 25 and 34.9 kg/m2
  • being able to walk without limitation

Who cannot join

  • cardiovascular, respiratory, gastrointestinal, neuromuscular, neurological, or psychiatric problems; musculoskeletal problems interfering with exercise
  • immunodeficiency problems
  • malignancies in the last 5 years
  • any other medical condition or life threatening disease that could be aggravated by exercise

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana, 70808

Other trials in United States

About this study

This feasibility study specifically addresses the issue of adapting US dietary guidelines physical activity recommendations to the population of the Lower Mississippi Delta. The hypothesis is that including a pedometer as a self-monitoring tool as part of adapted physical activity guidelines will result in greater immediate increases in physical activity (as monitored by an accelerometer) than an education program alone.

Read the detailed description

The purpose of this study was to determine if a short-term pedometer-based intervention results in immediate increases in time spent in moderate-to-vigorous physical activity (MVPA) compared to a minimal educational intervention.A sample of 43 overweight adults 35 to 64 years of age participated in a one week pedometer-based feasibility trial monitored by accelerometry. Participants were randomized into a one-week education-only group or a group that also wore a pedometer. Accelerometer-measured MVPA was measured over 7 days at baseline and post-intervention.

Being tested
Physical Activity Educational Materials, Pedometer
Keywords
pedometer, accelerometer, moderate-to-vigorous physical activity, adult, randomized trial
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical Activity Educational MaterialsBehavioural

    A brochure was provided to participants about the health benefits of physical activity and physical activity recommendations

  • PedometerBehavioural

    A pedometer was provided to participants in addition to educational materials about the health benefits of physical activity.

Study groups in NCT01264757
Study groupRoleWhat they receive
EducationActive comparatorEducational brochure about physical activity provided.
Receives: Behavioral: Physical Activity Educational Materials
PedometerExperimentalA pedometer was provided in addition to educational materials.
Receives: Behavioral: Pedometer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Minutes spent in moderate-to-vigorous physical activity (MVPA)

    A GT3X accelerometer is used to monitor each participants physical activity levels for seven consecutive days at baseline and again following a 7-day intervention period. The amount of time per day spent above a threshold of 2200 accelerometer counts/min is averaged over at least three days as the measure of MVPA.

    Measured: The primary outcome is measured at baseline and after a 7-day intervention period (1 week)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2010 (estimated)
  2. Study startFeb 2010
  3. Primary completionJun 2010
  4. Study completionJun 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01264757
Sponsor's protocol ID
PBRC 29034
Acronym
STEPS
Status last verified
Feb 2016
First submitted
3 Dec 2010
Last updated
5 Feb 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Katzmarzyk PT, Champagne CM, Tudor-Locke C, Broyles ST, Harsha D, Kennedy BM, Johnson WD. A short-term physical activity randomized trial in the Lower Mississippi Delta. PLoS One. 2011;6(10):e26667. doi: 10.1371/journal.pone.0026667. Epub 2011 Oct 25.

    PubMed 22046325
  • Harrington DM, Tudor-Locke C, Champagne CM, Broyles ST, Harsha DW, Kennedy BM, Johnson WD, Allen R, Katzmarzyk PT. Step-based translation of physical activity guidelines in the Lower Mississippi Delta. Appl Physiol Nutr Metab. 2011 Aug;36(4):583-5. doi: 10.1139/h11-053. Epub 2011 Aug 19.

    PubMed 21854159

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Physical Activity Educational Materials and Pedometer in people with Physical Inactivity, run by Pennington Biomedical Research Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Minutes spent in moderate-to-vigorous physical activity (MVPA) (time frame: The primary outcome is measured at baseline and after a 7-day intervention period (1 week)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01264757, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in